UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 49 filers reported holding UNUM THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $195,000 | – | 13,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 3,361,535 | $7,866,000 | 8.14% |
| Fairmount Funds Management LLC | 6,235,903 | $13,716,000 | 5.81% |
| Samsara BioCapital, LLC | 5,681,818 | $13,295,000 | 3.71% |
| VR Adviser, LLC | 4,355,273 | $10,191,000 | 1.99% |
| New Leaf Venture Partners, L.L.C. | 1,795,545 | $4,040,000 | 1.63% |
| Logos Global Management LP | 2,700,000 | $6,318,000 | 0.81% |
| Perceptive Advisors | 7,955,000 | $18,615,000 | 0.27% |
| ACUTA CAPITAL PARTNERS, LLC | 410,000 | $959,000 | 0.26% |
| Soleus Capital Management, L.P. | 47,900 | $112,000 | 0.06% |
| Polar Capital LLP | 2,500,000 | $5,850,000 | 0.04% |